Market Overview

Transition Therapeutics, Inc. (NASDAQ: TTHI)

2.19 +0.01 (0.46%)

Analyst Ratings

DateResearch FirmActionCurrentPT
4/06/15Cowen & CompanyInitiates Coverage onMarket Perform
12/10/13Canaccord GenuityUpgradesSpeculative Buy9.8
2/12/13Byron Capital MarketsUpgradesSpeculative Buy
8/31/12CanaccordMaintainsHold2.3

Data powered by Benzinga PRO Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter